A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

Published 2013 View Full Article

Authors

Keywords

Journal

PAIN

Volume 154, Issue 9, Pages 1542-1550

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2013-04-17

DOI

10.1016/j.pain.2013.04.024

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

PAIN

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Ask a Question. Answer a Question.